Work

FIGURE 1 from A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors

Year: 2023

Type: other

Abstract: Mean relative change in platelet count from baseline per dose level in cycle 1 (%). C, cycle; D, day.

DOI: 10.1158/2767-9764.24025935.v1

Authors: Michael A. Carducci, Ding Wang, Christina Habermehl, Matthias Bödding, Felix Rohdich, Floriane Lignet, Klaus Duecker, Oleksandr Karpenko, Linda Pudelko, Claude Gimmi, Patricia LoRusso

Language: English

Topic: Peptidase Inhibition and Analysis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4386186155

Cites:

Cited by:

Related to: 10